The diagnosis and treatment of neuroleptic-induced Parkinsonism.
Basal ganglia side-effects caused by neuroleptic drugs are frequently ignored, misdiagnosed, or mistreated by the patient or physician. Such side-effects must be anticipated and appropriate management instituted so that patient compliance with the drug regimen is increased and the therapeutic relationship is maintained. Side-effects can be detected in frequent and complete examinations of the head and neck, limbs, and chest and back. The various medications for drug-induced parkinsonism are reviewed, with an emphasis on the indications for selection and the effects of each drug. Common errors in the diagnosis and management of side-effects of neuroleptic drugs are summarized.
D014150:Antipsychotic Agents / Q000009:adverse effects; D003863:Depression / Q000175:diagnosis; D003937:Diagnosis, Differential; D004155:Diphenhydramine / Q000627:therapeutic use; D006801:Humans; D009460:Neurologic Examination; D009966:Orphenadrine / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D010349:Patient Compliance
D014150:Antipsychotic Agents; D004155:Diphenhydramine; D009966:Orphenadrine